It’s officially earnings season, which can only mean one thing: Johnson & Johnson (NYSE:JNJ) is kicking things off for big pharmaceutical companies.
On Tuesday morning, July 18, Johnson & Johnson released its second-quarter earnings results, keeping alive a recent trend of better-than-expected profits and lower-than-anticipated sales.
